Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating HPVDNA in patients undergoing transoral robotic surgery for oropharyngeal cancer: liquid biopsy could identify molecular residual disease.
Campo F, Paolini F, Terrenato I, Blandino G, Pascale V, Locca O, Moretto S, Manciocco V, Vidiri A, Venuti A, Pellini R. Campo F, et al. Among authors: blandino g. Eur Arch Otorhinolaryngol. 2025 Jan 25. doi: 10.1007/s00405-025-09218-x. Online ahead of print. Eur Arch Otorhinolaryngol. 2025. PMID: 39863814
Cancer Organoids as reliable disease models to drive clinical development of novel therapies.
Blandino G, Satchi-Fainaro R, Tinhofer I, Tonon G, Heilshorn SC, Kwon YJ, Pestana A, Frascolla C, Pompili L, Puce A, Iachettini S, Tocci A, Karkampouna S, Kruithof-de Julio M, Tocci P, Porciello N, Maccaroni K, Rutigliano D, Shen X, Ciliberto G. Blandino G, et al. J Exp Clin Cancer Res. 2024 Dec 28;43(1):334. doi: 10.1186/s13046-024-03258-7. J Exp Clin Cancer Res. 2024. PMID: 39731178 Free PMC article.
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial.
Meattini I, De Santis MC, Visani L, Scorsetti M, Fozza A, Meduri B, De Rose F, Bonzano E, Prisco A, Masiello V, La Rocca E, Spoto R, Becherini C, Blandino G, Moscetti L, Colciago RR, Audisio RA, Brain E, Caini S, Hamaker M, Kaidar-Person O, Lambertini M, Marrazzo L, Saieva C, Spanic T, Strnad V, Wheelwright S, Poortmans PMP, Livi L; EUROPA Trial Investigators. Meattini I, et al. Among authors: blandino g. Lancet Oncol. 2025 Jan;26(1):37-50. doi: 10.1016/S1470-2045(24)00661-2. Epub 2024 Dec 12. Lancet Oncol. 2025. PMID: 39675376 Clinical Trial.
Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues.
Sanghvi N, Calvo-Alcañiz C, Rajagopal PS, Scalera S, Canu V, Sinha S, Schischlik F, Wang K, Madan S, Shulman E, Papanicolau-Sengos A, Blandino G, Ruppin E, Nair NU. Sanghvi N, et al. Among authors: blandino g. Sci Adv. 2024 Dec 6;10(49):eadn0220. doi: 10.1126/sciadv.adn0220. Epub 2024 Dec 6. Sci Adv. 2024. PMID: 39642223 Free PMC article.
Once-a-Week Ablative Radiotherapy as Replacement of Prolonged Fractionation in Frail Patients: Feasibility and Toxicity Results.
Belgioia L, Satragno C, Blandino G, Fozza A, Giannelli F, Marcenaro M, Vidano G, Picichè F, Lanfranchi F, Tagliafico A, Sambuceti G, Bauckneht M, Timon G. Belgioia L, et al. Among authors: blandino g. Cancer Invest. 2024 Nov;42(10):893-898. doi: 10.1080/07357907.2024.2425729. Epub 2024 Nov 6. Cancer Invest. 2024. PMID: 39501923
Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer.
Piastra V, Ganci F, Sacconi A, Pranteda A, Allegretti M, Bernardini R, Serra M, Lupo B, Dell'Aquila E, Ferretti G, Pescarmona E, Bartolazzi A, Blandino G, Trusolino L, Bossi G. Piastra V, et al. Among authors: blandino g. J Exp Clin Cancer Res. 2024 Aug 20;43(1):234. doi: 10.1186/s13046-024-03150-4. J Exp Clin Cancer Res. 2024. PMID: 39164711 Free PMC article.
471 results